Canopy
Zellkraftwerk

Latest News

29

Apr 19

Canopy Biosciences Acquires Zellkraftwerk GmbH

Simultaneously Closes Strategic Growth Investment from Ampersand Capital to Create a Leading Provider of Genomic and Cell and Tissue Analysis...
Read More

29

Mar 19

Canopy Biosciences Launches New Technology Vastly Improving Sensitivity of Next Generation Sequencing

ST. LOUIS, March 29, 2019 -- Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and...
Read More

5

Mar 19

Canopy Biosciences Announces Exclusive License for Error Corrected Sequencing Technology

ST. LOUIS, March 5, 2019 /PRNewswire/ -- Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products...
Read More

9

Oct 18

Canopy Biosciences Announces Catalog of Genetically Engineered Cell Lines and Lysates

Canopy brings CRISPR technology within the reach of millions of researchers worldwide. Canopy BiosciencesTM, LLC, an established provider of gene...
Read More
0

Start typing and press Enter to search